Literature DB >> 35870006

Noninvasive photoacoustic computed tomography/ultrasound imaging to identify high-risk atherosclerotic plaques.

Xuewei Liu1, Rongkang Gao2, Chiyun Chen3, Xiaobo Li1, Chen Yu1, Yejia Chen1, Hongbin Liang1, Min Xiao1, Lei Dai1, Shifeng Qiu1, Xiaoyu Xin1, Liang Song2, Jinbin Liu4, Chengbo Liu5, Jiancheng Xiu6.   

Abstract

PURPOSE: Noninvasive detection of high-risk plaques is still challenging. In this study, we aimed to noninvasively assess αvβ3-integrin expression using a customed photoacoustic (PA) computed tomography (PACT)/ultrasound (US) system in atherosclerotic lesions of varying degrees of severity and to explore its potential value for detecting high-risk plaques.
METHODS: We constructed αvβ3-integrin-targeted ultrasmall gold nanorods (AuNRs) with cyclo Arg-Gly-Asp (cRGD) and tested their properties. Employing C57BL/6 J (wild-type, WT) mice and apolipoprotein E gene knockout (ApoE-/-) mice fed either a chow diet or a high-fat/high-cholesterol diet (HFHCD), we established varying degrees of lesion severity. In vivo PACT/US imaging was performed to assess αvβ3-integrin expression in the 4 groups by cRGD-AuNRs. Further histopathologic examination was conducted to evaluate the plaque vulnerability indicators.
RESULTS: The data showed that cRGD-AuNRs exhibited excellent photothermal conversion capacity, stability, targeting ability, and biocompatibility. The immunohistochemical results indicated that αvβ3-integrin was upregulated with increasing aggravation of the lesions. In vivo PACT/US imaging showed good consistency with αvβ3-integrin expression. Notably, ApoE-/- mice fed a HFHCD showed an abrupt PA intensity increase compared with the other groups. The histopathologic examination verified that the atherosclerotic plaques of ApoE-/- mice fed the HFHCD developed unstable phenotypes. Correlation analysis showed that PA intensity was mainly related to inflammation and angiogenesis among all of the indicators.
CONCLUSION: Our data indicated that αvβ3-integrin is an effective indicator of plaque instability, and noninvasive PACT/US molecular imaging assessment of αvβ3-integrin holds promise in detecting high-risk plaques.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Gold nanorods; High-risk atherosclerotic plaque; Molecular imaging; Photoacoustic computed tomography; αvβ3-integrin

Year:  2022        PMID: 35870006     DOI: 10.1007/s00259-022-05911-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  39 in total

Review 1.  Imaging the vulnerable plaque.

Authors:  David Vancraeynest; Agnes Pasquet; Véronique Roelants; Bernhard L Gerber; Jean-Louis J Vanoverschelde
Journal:  J Am Coll Cardiol       Date:  2011-05-17       Impact factor: 24.094

2.  PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.

Authors:  Ambros J Beer; Jaroslav Pelisek; Peter Heider; Antti Saraste; Christian Reeps; Stephan Metz; Stefan Seidl; Horst Kessler; Hans-Jürgen Wester; Hans Henning Eckstein; Markus Schwaiger
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

3.  Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma: An ALTAIR Trial Report.

Authors:  Yoichiro Sugizaki; Hiromasa Otake; Hiroyuki Kawamori; Takayoshi Toba; Yuichiro Nagano; Yoshiro Tsukiyama; Ken-Ichi Yanaka; Hiroyuki Yamamoto; Akira Nagasawa; Hiroyuki Onishi; Ryo Takeshige; Shinsuke Nakano; Yoichiro Matsuoka; Kosuke Tanimura; Yu Takahashi; Yusuke Fukuyama; Toshiro Shinke; Tatsuro Ishida; Ken-Ichi Hirata
Journal:  JACC Cardiovasc Imaging       Date:  2020-03-18

4.  Vulnerable plaques and patients: state-of-the-art.

Authors:  Mariusz Tomaniak; Yuki Katagiri; Rodrigo Modolo; Ranil de Silva; Ramzi Y Khamis; Christos V Bourantas; Ryo Torii; Jolanda J Wentzel; Frank J H Gijsen; Gijs van Soest; Peter H Stone; Nick E J West; Akiko Maehara; Amir Lerman; Antonius F W van der Steen; Thomas F Lüscher; Renu Virmani; Wolfgang Koenig; Gregg W Stone; James E Muller; William Wijns; Patrick W Serruys; Yoshinobu Onuma
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

5.  Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.

Authors:  Aernoud T L Fiolet; Tjerk S J Opstal; Arend Mosterd; John W Eikelboom; Sanjit S Jolly; Anthony C Keech; Peter Kelly; David C Tong; Jaimie Layland; Stefan M Nidorf; Peter L Thompson; Charley Budgeon; Jan G P Tijssen; Jan H Cornel
Journal:  Eur Heart J       Date:  2021-03-26       Impact factor: 29.983

6.  A prospective natural-history study of coronary atherosclerosis.

Authors:  Gregg W Stone; Akiko Maehara; Alexandra J Lansky; Bernard de Bruyne; Ecaterina Cristea; Gary S Mintz; Roxana Mehran; John McPherson; Naim Farhat; Steven P Marso; Helen Parise; Barry Templin; Roseann White; Zhen Zhang; Patrick W Serruys
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

Review 7.  Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.

Authors:  Eric A Osborn; Chase W Kessinger; Ahmed Tawakol; Farouc A Jaffer
Journal:  J Nucl Med       Date:  2017-04-27       Impact factor: 10.057

8.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

Authors:  A C van der Wal; A E Becker; C M van der Loos; P K Das
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  αVβ3 integrin-targeted microSPECT/CT imaging of inflamed atherosclerotic plaques in mice.

Authors:  David Vancraeynest; Véronique Roelants; Caroline Bouzin; François-Xavier Hanin; Stephan Walrand; Vanesa Bol; Anne Bol; Anne-Catherine Pouleur; Agnès Pasquet; Bernhard Gerber; Philippe Lesnik; Thierry Huby; François Jamar; Jean-Louis Vanoverschelde
Journal:  EJNMMI Res       Date:  2016-03-24       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.